Individuals who are immunocompromised (including those receiving chemotherapy, taking immunosuppressants, or living with HIV), those with central venous catheters, people with severe acute pancreatitis, and patients in intensive care settings should consult their healthcare team before starting probiotics
A 2024 pharmaceutical review in Pharmaceuticals raised tumorigenesis as a theoretical risk, though a 2025 response published in the same journal directly countered the concerns
A 2015 review published in BioMed Research International by Pickart, Vasquez-Soltero, and Margolina provided a comprehensive overview of GHK-Cu as a natural modulator of multiple cellular pathways in skin regeneration
The conversion of homocysteine to methionine reduces the potential for damage because the reaction results in the formation of the super-antioxidant glutathione
Retatrutide should not be used by anyone who is pregnant, breastfeeding, or has an existing health condition